EV/EBITDA
-4.24
-0.16-3.92%
88 min ago
Summary
- As of March 13, 2025, ARWR EV/EBITDA is -4.24, with a fall of -0.16 (-3.92%) during the most recent trading day.
- Over the past year, ARWR EV/EBITDA has increased by +9.14 (+68.31%).
- ARWR EV/EBITDA is now -100.60% below its all-time high of 710.38.
Performance
ARWR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ARWR EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -3.9% | +3.8% | +4.7% |
| 1 m1 month | +10.6% | -10.7% | -12.9% |
| 3 m3 months | +24.3% | -21.7% | -28.2% |
| 6 m6 months | +17.0% | -5.2% | -23.0% |
| ytdytd | +13.5% | -13.5% | -16.6% |
| 1 y1 year | +68.3% | -31.5% | -44.7% |
| 5 y5 years | -110.1% | +17.4% | -37.0% |
ARWR EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.9% | -5.46 | +22.3% | |
| 3 m | 3-month | -4.08 | -3.9% | -5.67 | +25.2% |
| 6 m | 6-month | -4.08 | -3.9% | -6.62 | +36.0% |
| 1 y | 1-year | -4.08 | -3.9% | -13.45 | +68.5% |
| 3 y | 3-year | -4.08 | -3.9% | -54.05 | +92.2% |
| 5 y | 5-year | 710.38 | -100.6% | -179.20 | +97.6% |
| alltime | all time | 710.38 | -100.6% | -422.40 | +99.0% |
Arrowhead Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -4.24(-13.5%) |
| 2024 | -4.90(-61.5%) |
| 2023 | -12.74(-57.0%) |
| 2022 | -29.64(-26.3%) |
| 2021 | -40.22(-45.4%) |
| 2020 | -73.69(-161.6%) |
| 2019 | 119.55(-429.2%) |
| 2018 | -36.31(+325.7%) |
| 2017 | -8.53(+3777.3%) |
| 2016 | -0.22(-93.7%) |
| 2015 | -3.49(-21.0%) |
| 2014 | -4.42(-71.3%) |
| 2013 | -15.38(+837.8%) |
| Date | Value |
|---|---|
| 2012 | -1.64(-59.2%) |
| 2011 | -4.02(-75.2%) |
| 2010 | -16.24(+552.2%) |
| 2009 | -2.49(+151.5%) |
| 2008 | -0.99(-67.9%) |
| 2007 | -3.08(-49.7%) |
| 2006 | -6.12(-44.2%) |
| 2005 | -10.96(-18.3%) |
| 2004 | -13.41(-303.8%) |
| 2003 | 6.58(-1500.0%) |
| 2002 | -0.47(-93.0%) |
| 2001 | -6.69(-21.6%) |
| 2000 | -8.53(-68.6%) |
| 1999 | -27.17 |
FAQ
- What is Arrowhead Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Arrowhead Pharmaceuticals?
- What is ARWR EV/EBITDA year-to-date change?
- What is Arrowhead Pharmaceuticals EV/EBITDA year-on-year change?
What is Arrowhead Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of ARWR is -4.24
What is the all time high EV/EBITDA for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high EV/EBITDA is 710.38
What is ARWR EV/EBITDA year-to-date change?
Arrowhead Pharmaceuticals EV/EBITDA has changed by +0.66 (+13.47%) since the beginning of the year
What is Arrowhead Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, ARWR EV/EBITDA has changed by +9.14 (+68.31%)